江苏久吾高科技股份有限公司 2024 年度审计报告 中国杭州市钱江新城新业路 8 号 UDC 时代大厦 A 座 5-8 层、12 层、23 层 www.zhcpa.cn Floors5-8,12and23,Block A,UDC Times Building,No.8 Xinye Road，Qianjiang New City,Hangzhou Tel.0571-88879999 Fax.0571-88879000 目 录 | | 页 次 | | --- | --- | | 一、审计报告 | 1-6 | | 二、财务报表 | 7-8 | | (一) 合并资产负债表 | 7-8 | | (二) 合并利润表 | 9 | | (三) 合并现金流量表 | 10 | | (四) 合并所有者权益变动表 | 11-12 | | (五) 母公司资产负债表 | 13-14 | | (六) 母公司利润表 | 15 | | (七) 母公司现金流量表 | 16 | | (八) 母公司所有者权益变动表 | 17-18 | 三、财务报表附注 19-136 中国杭州市钱江新城新业路 8 号 UDC 时代大厦 A 座 5-8 层、12 层、 ...

江苏久吾高科技股份有限公司 独立董事 2024 年度述职报告（王兵） 各位股东及股东代表： 本人王兵，作为江苏久吾高科技股份有限公司（以下简称"公司"）的独立 董事，2024 年严格按照《中华人民共和国公司法》《上市公司独立董事管理办 法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监 管指引第 2 号——创业板上市公司规范运作》等相关法律、法规、规范性文件及 《公司章程》《公司独立董事工作制度》的有关规定，认真履行职责，充分发挥 独立董事的独立作用，维护公司整体利益，也维护了全体股东特别是中小股东的 合法权益。现将 2024 年度本人履行独立董事职责工作情况向各位股东汇报如下： 一、基本情况 本人王兵，1978 年生，中国国籍，无境外永久居留权，会计学博士学位。 2007 年 7 月至今，就职于南京大学商学院会计学系，现任会计学系教授、系副 主任。现任中国审计学会理事、中国内部审计协会理事。2019 年 6 月至 2024 年 5 月，担任哈焊所华通(常州)焊业股份有限公司独立董事；现任旷达科技集团股 份有限公司、华泰证券股份有限公司独立董事，2022 年 6 月至今，担任公司独 立董事 ...

江苏久吾高科技股份有限公司 独立董事 2024 年度述职报告（陈红） 各位股东及股东代表： 本人陈红，作为江苏久吾高科技股份有限公司（以下简称"公司"）的独立 董事，2024 年严格按照《中华人民共和国公司法》《上市公司独立董事管理办 法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监 管指引第 2 号——创业板上市公司规范运作》等相关法律、法规、规范性文件及 《公司章程》《公司独立董事工作制度》的有关规定，认真履行职责，充分发挥 独立董事的独立作用，维护公司整体利益，也维护了全体股东特别是中小股东的 合法权益。现将 2024 年度本人履行独立董事职责工作情况向各位股东汇报如下： 一、基本情况 二、2024 年度履职情况 （一）出席董事会和股东大会会议情况 本人出席公司董事会会议和股东大会的具体情况如下： | 董事会召 | 应当出席 | 亲自出席 | 委托出席 | 缺席次数 | 股东大会 | 列席股东 | | --- | --- | --- | --- | --- | --- | --- | | 开次数 | 次数 | 次数 | 次数 | | 召开次数 | 大会次数 | | 7 | 7 | ...

江苏久吾高科技股份有限公司 章 程 二〇二五年四月 | 第一章 | 总则 3 | | --- | --- | | 第二章 | 经营宗旨和范围 4 | | 第三章 | 股份 5 | | 第一节 | 股份发行 5 | | 第二节 | 股份增减和回购 6 | | 第三节 | 股份转让 7 | | 第四章 | 股东和股东大会 8 | | 第一节 | 股东 8 | | 第二节 | 股东大会的一般规定 12 | | 第三节 | 股东大会的召集 18 | | 第四节 | 股东大会的提案与通知 19 | | 第五节 | 股东大会的召开 21 | | 第六节 | 股东大会的表决和决议 25 | | 第五章 | 董事会 31 | | 第一节 | 董事 31 | | 第二节 | 董事会 35 | | 第六章 | 总经理及其他高级管理人员 41 | | 第七章 | 监事会 43 | | 第一节 | 监事 43 | | 第二节 | 监事会 44 | | 第八章 | 财务会计制度、利润分配和审计 46 | | 第一节 | 财务会计制度 46 | | 第二节 | 内部审计 50 | | 第三节 | 会计师事务所的聘任 51 | | 第九章 ...

独立董事 2024 年度述职报告（朱玉华） 各位股东及股东代表： 本人朱玉华，作为江苏久吾高科技股份有限公司（以下简称"公司"）的独 立董事，2024 年严格按照《中华人民共和国公司法》《上市公司独立董事管理 办法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律 监管指引第 2 号——创业板上市公司规范运作》等相关法律、法规、规范性文件 及《公司章程》《公司独立董事工作制度》的有关规定，认真履行职责，充分发 挥独立董事的独立作用，维护公司整体利益，也维护了全体股东特别是中小股东 的合法权益。现将 2024 年度本人履行独立董事职责工作情况向各位股东汇报如 下： 一、基本情况 本人朱玉华，1962 年生，中国国籍，无境外永久居留权，硕士研究生学历。 1988 年 3 月至 2022 年 10 月，就职于有色金属技术经济研究院，曾担任标准中 心副主任、主任、院长助理、副院长。现任全国有色金属标准化技术委员会顾问、 国家新材料产业发展专家咨询委员会委员、中国标准化专家委员会委员；曾任永 臻科技股份有限公司独立董事；2022 年 6 月起任江西特种电机股份有限公司独 立董事；2023 年 5 月至今 ...

江苏久吾高科技股份有限公司董事会 根据《上市公司独立董事管理办法》《上市公司自律监管指引第2号——创业板 上市公司规范运作》等要求，江苏久吾高科技股份有限公司（以下简称"公司"） 董事会，就公司在任独立董事陈红、朱玉华、王兵的独立性情况进行评估并出具如 下专项意见： 1 董事会 2025 年 4 月 20 日 关于独立董事独立性情况的专项意见 经核查独立董事陈红、朱玉华、王兵的任职经历以及签署的相关自查文件，公 司董事会认为上述人员未在公司担任除独立董事以外的任何职务，也未在公司主要 股东担任任何职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进 行独立客观判断的关系，不存在其他影响独立董事独立性的情况。公司独立董事符 合《上市公司独立董事管理办法》《上市公司自律监管指引第2号——创业板上市公 司规范运作》中对独立董事独立性的相关要求。 江苏久吾高科技股份有限公司 ...

Financial Performance - The company's operating revenue for 2024 was ¥533,286,878.20, a decrease of 29.55% compared to ¥756,999,521.77 in 2023[22]. - Net profit attributable to shareholders for 2024 was ¥53,015,388.07, an increase of 16.90% from ¥45,350,453.73 in 2023[22]. - The cash flow from operating activities for 2024 was ¥93,991,028.56, representing a significant increase of 78.41% compared to ¥52,682,213.10 in 2023[22]. - The total assets at the end of 2024 were ¥1,929,053,493.24, reflecting a 1.90% increase from ¥1,893,031,949.03 at the end of 2023[22]. - The net profit after deducting non-recurring gains and losses for 2024 was ¥47,192,676.09, a 20.09% increase from ¥39,297,675.63 in 2023[22]. - The company's operating revenue for the specialized equipment manufacturing industry was approximately CNY 406.62 million, a decrease of 38.34% compared to the same period last year, with a gross margin of 34.52%, up 7.72% year-on-year[83]. - The overall gross profit margin improved due to the sales of new products and efficiency enhancement initiatives, contributing to the growth in net profit[73]. - The company reported a significant increase in inventory levels for ceramic membrane components, with production volume rising by 57.96% year-on-year to 5.26 million square meters[84]. Research and Development - The company emphasizes its commitment to R&D in lithium adsorption materials, which are designed to selectively extract lithium ions from brine solutions[18]. - Research and development expenses amounted to ¥56.23 million, representing 10.54% of total revenue, indicating a strong commitment to innovation[66]. - The company has established a complete R&D system for separation materials and technologies, supported by multiple provincial and national research platforms[56]. - The company holds 106 effective invention patents, 119 utility model patents, and 5 design patents, with 118 patent applications accepted[66]. - The company is focused on the research and application of separation materials such as ceramic membranes, organic membranes, and lithium adsorbents, providing integrated membrane technology solutions for industrial separation and environmental water treatment[46]. - The company has developed a "adsorption + membrane" lithium extraction process, applicable to various types of brine resources, showcasing its technological innovation[65]. - The company is in the pilot phase of lithium extraction technology, aiming to enhance its market competitiveness in lithium extraction from salt lakes[96]. Market Expansion and Strategy - The company is actively pursuing market expansion strategies, particularly in the field of membrane separation technology and water treatment solutions[18]. - The company is actively expanding its overseas market presence, successfully winning multiple international projects in Southeast Asia and South America[75]. - The company plans to enter two new international markets by Q2 2024, targeting a revenue contribution of $100 million[9]. - The company aims to maintain a strong market position by continuously investing in R&D for separation materials and application technologies[44]. - The company has seen substantial support from government policies aimed at promoting the application of membrane materials and separation technologies[33]. - The company is investing $50 million in R&D for new technologies aimed at enhancing product efficiency[5]. - The company completed a strategic acquisition for $200 million, expected to enhance its product portfolio[7]. Governance and Compliance - The company strictly adheres to relevant laws and regulations, ensuring compliance with corporate governance standards set by the China Securities Regulatory Commission and Shenzhen Stock Exchange[148]. - The board of directors consists of 9 members, including 3 independent directors, meeting legal requirements for composition[150]. - The company has established specialized committees within the board, including a strategic committee and an audit committee, to enhance decision-making processes[152]. - The company has implemented an internal audit system to monitor compliance and risk management effectively[157]. - The company has no significant discrepancies in governance practices compared to regulatory requirements[159]. - The company actively engages in investor relations, ensuring timely and accurate information disclosure to all shareholders[156]. Shareholder Engagement and Remuneration - The annual shareholders' meeting had a participation rate of 30.73% on April 12, 2024, ensuring shareholder engagement[163]. - The total remuneration of 6.5454 million yuan for 18 directors, supervisors, and senior management during the reporting period[189]. - The company has a performance-based salary system for senior management, which includes basic salary and performance annual salary[188]. - The total remuneration for the deputy general manager and board secretary, Cheng Heng, was 703,500 yuan[191]. - The company has established a compensation and assessment committee under the board of directors to formulate salary plans[186]. Product Development and Innovation - The company has developed a ceramic membrane continuous reaction separation technology that has been applied in the metallurgical and steel industries, aligning with national policies for energy conservation and emission reduction[38]. - The company successfully launched high-filled ceramic membranes, achieving over 50% increase in flux compared to traditional processes, and gained market recognition in industrial water treatment[75]. - The fourth-generation aluminum lithium adsorbent was successfully developed, with adsorption capacity increased by 30%-50% compared to the previous generation, showcasing the company's innovation capabilities[74]. - The company aims to improve the recovery rate of acid in waste acid treatment technology to over 70%, with a 10% increase in acid recovery rate compared to traditional methods[98]. Financial Management and Investments - The company has utilized 98.12% of the raised funds from the public offering of convertible bonds, totaling ¥24,096.73 million[116]. - The company reported a pledge of accounts receivable amounting to ¥50,504,117.96 for issuing acceptance bills[111]. - The company has committed to a total investment of 345.28 million yuan across various projects, with a cumulative investment of 355.97 million yuan reported[123]. - The company has not reported any issues in the use and disclosure of raised funds[127]. - The company has a remaining balance of 3,020.71 million from the stock issuance, also stored in the special account[127].

Financial Performance - The company's revenue for Q1 2025 was ¥86,434,031.64, representing a 6.53% increase compared to ¥81,133,318.95 in the same period last year[4] - Net profit attributable to shareholders was ¥17,664,537.67, marking a 25.94% increase from ¥14,026,239.47 year-over-year[4] - Basic earnings per share increased by 26.78% to ¥0.1463 from ¥0.1154 in the previous year[4] - Total operating revenue for the current period reached ¥86,434,031.64, an increase from ¥81,133,318.95 in the previous period, representing a growth of approximately 4.3%[37] - Net profit for the current period was ¥17,662,298.04, compared to ¥14,066,989.57 in the previous period, reflecting an increase of approximately 25.0%[38] - Total comprehensive income for the period reached ¥17,662,298.04, an increase from ¥14,066,989.57 in the previous period, representing a growth of approximately 25.5%[39] - Basic earnings per share increased to ¥0.1463 from ¥0.1154, reflecting a growth of 26.5%[39] Cash Flow and Liquidity - The net cash flow from operating activities decreased significantly by 796.20%, dropping to -¥20,732,329.71 from ¥2,977,943.44 in the same period last year[4] - Cash inflow from operating activities totaled ¥109,072,808.90, down from ¥123,071,044.74, indicating a decrease of about 11.4%[41] - Cash outflow from operating activities increased to ¥129,805,138.61 from ¥120,093,101.30, marking an increase of approximately 8.9%[42] - Investment activities resulted in a net cash outflow of ¥119,963,610.53, compared to a net inflow of ¥3,337,239.76 in the previous period[42] - Cash and cash equivalents decreased from ¥318,361,148.98 to ¥246,390,002.55, reflecting a decline of approximately 22.6%[33] - Cash and cash equivalents at the end of the period were ¥206,433,916.28, slightly up from ¥199,031,136.26[42] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,960,026,856.38, a 1.61% increase from ¥1,929,053,493.24 at the end of the previous year[6] - Current liabilities totaled ¥619,331,116.77, slightly increasing from ¥616,145,615.25, showing a marginal rise of approximately 0.4%[35] - The company's equity attributable to shareholders increased to ¥1,271,757,037.37 from ¥1,245,460,188.78, marking a growth of about 2.1%[35] Expenses - Management expenses increased by 88.65% year-over-year, primarily due to costs associated with restricted stock[13] - Financial expenses surged by 1395.63% compared to the previous year, mainly due to adjustments in exchange rate gains and losses[14] - Research and development expenses for the current period were ¥10,967,549.09, compared to ¥11,247,258.42 in the previous period, indicating a decrease of approximately 2.5%[38] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 15,771, with the largest shareholder holding 25.59% of the shares[22] - The company reported a total of 5,246,218 shares under lock-up agreements, with no shares released or added during the current period[27] - The company has a total of 1,865,000 shares reserved for the 2024 restricted stock incentive plan, with 20,000 shares added this period[29] Other Income - The company received government subsidies amounting to ¥4,355,279.35, contributing to other income growth of 168.57% year-over-year[15] - The company reported an investment income of ¥3,559,966.35, up from ¥2,658,942.35, representing an increase of approximately 33.8%[38] Investment and Recovery - The company reported a decrease in cash received from the recovery of investments, totaling ¥20,000,000.00, down from ¥40,000,000.00[42] - The company did not report any net profit from subsidiaries prior to consolidation, consistent with the previous period[39]

久吾高科（300631）公告，2024年营业收入5.33亿元，同比下降29.55%。归属于上市公司股东的净利润 5301.54万元，同比增长16.90%。基本每股收益0.4319元/股，同比增长16.76%。公司拟向全体股东每10 股派发现金红利1.8元(含税)，送红股0股(含税)，以资本公积金向全体股东每10股转增0股。 ...

证券代码：300631 证券简称：久吾高科 公告编号：2025-013 江苏久吾高科技股份有限公司 关于提请股东大会授权董事会以简易程序向特定对象发行股票 的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 江苏久吾高科技股份有限公司（以下简称"公司"）于 2025 年 4 月 20 日召 开公司第八届董事会第十六次会议，审议通过了《关于提请股东大会授权董事会 以简易程序向特定对象发行股票的议案》，同意提请股东大会授权董事会及董事 会授权人士以简易程序向特定对象发行融资总额不超过人民币三亿元且不超过 最近一年末净资产 20%的股票，授权期限为公司 2024 年度股东大会通过之日起 至 2025 年度股东大会召开之日止。现将有关事项公告如下： 一、 授权具体内容 （一）确认公司是否符合以简易程序向特定对象发行股票（以下简称"小额 快速"或"本次发行股票"）的条件 授权董事会根据《中华人民共和国公司法》《中华人民共和国证券法》《上 市公司证券发行注册管理办法》等法律、法规、规范性文件以及《公司章程》的 规定，对公司实际情况及相关事项进行自查论证，并确认公司是否 ...